The antioxidant protein peroxiredoxin 6 (PRDX6) that lowers MMP9 expression, fibrinogen leakage, and free radical damage, is also elevated in astrocytes of MS patients and EAE mice [132]. Here, PRDX6 is linked to myeloid sarcoma.